Venous thrombosis with cyproterone (continued).
D000152:Acne Vulgaris / Q000188:drug therapy; D000293:Adolescent; D000328:Adult; D000726:Androgen Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D002170:Canada; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects / Q000627:therapeutic use; D003534:Cyproterone / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005602:France; D006801:Humans; D016912:Levonorgestrel / Q000009:adverse effects / Q000627:therapeutic use; D012307:Risk Factors; D020246:Venous Thrombosis / Q000139:chemically induced* / Q000453:epidemiology
D000726:Androgen Antagonists; D003278:Contraceptives, Oral, Hormonal; D016912:Levonorgestrel; D003534:Cyproterone